PMID- 34559121 OWN - NLM STAT- MEDLINE DCOM- 20211005 LR - 20231004 IS - 1536-5964 (Electronic) IS - 0025-7974 (Print) IS - 0025-7974 (Linking) VI - 100 IP - 38 DP - 2021 Sep 24 TI - Risk factors and management of pulmonary infection in elderly patients with heart failure: A retrospective analysis. PG - e27238 LID - 10.1097/MD.0000000000027238 [doi] LID - e27238 AB - Pulmonary infection is common in patients with heart failure, yet the risk factors remain unclear. We aimed to evaluate the clinical characteristics and risk factors of pulmonary infection in elderly patients with heart failure, to provide reference to the prevention of pulmonary infection.This study was a retrospective study design. We included elderly heart failure patient admitted to our hospital from April 1, 2018 to August 31, 2020. The characteristics and clinical data of pulmonary infection and no infection patients were assessed. Logistic regression analyses were conducted to identify the risk factors of pulmonary infections in patients with heart failure.A total of 201 patients were included. The incidence of pulmonary infection in patients with heart failure was 23.88%. There were significant differences in the age, diabetes, New York Heart Association (NYHA) grade, left ventricular ejection fraction (LVEF), C-reactive protein (CRP) between infection and no infection group (all P < .05), and there were not differences in the sex, body mass index, alcohol drinking, smoking, hypertension, hyperlipidemia, length of hospital stay between 2 groups (all P > .05). Logistic regression analyses indicated that age >/=70 years, diabetes, NYHA grade III, LVEF /=10 mg/L were the independent risk factors of pulmonary infections in patients with heart failure (all P < .05). Pseudomonas aeruginosa (34.48%), Staphylococcus aureus (19.57%), and Klebsiella pneumoniae (15.22%) were the most common 3 pathogens in patients with pulmonary infection.Heart failure patients with age >/=70 years, diabetes, NYHA grade III, LVEF /=10 mg/L have higher risks of pulmonary infections, preventive measures targeted on those risk factors are needed to reduce pulmonary infections. CI - Copyright (c) 2021 the Author(s). Published by Wolters Kluwer Health, Inc. FAU - Peng, Qi AU - Peng Q AD - Cardiac Surgery, Wuhan Asia Heart Hospital, Jianghan District, Wuhan, Hubei, China. FAU - Yang, Qin AU - Yang Q AUID- ORCID: 0000-0003-2677-9449 AD - Pharmacy Intravenous Admixture Services, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Jiangan District, Wuhan, Hubei, China. LA - eng PT - Journal Article PL - United States TA - Medicine (Baltimore) JT - Medicine JID - 2985248R RN - 9007-41-4 (C-Reactive Protein) SB - IM MH - Aged MH - Aged, 80 and over MH - C-Reactive Protein MH - Female MH - Geriatrics/methods/trends MH - Heart Failure/*complications/therapy MH - Humans MH - Male MH - Respiratory Tract Infections/complications/*therapy MH - Retrospective Studies MH - Risk Factors PMC - PMC10545257 COIS- The authors report no conflicts of interest. EDAT- 2021/09/25 06:00 MHDA- 2021/10/06 06:00 PMCR- 2021/09/24 CRDT- 2021/09/24 12:17 PHST- 2020/12/31 00:00 [received] PHST- 2021/08/21 00:00 [accepted] PHST- 2021/09/24 12:17 [entrez] PHST- 2021/09/25 06:00 [pubmed] PHST- 2021/10/06 06:00 [medline] PHST- 2021/09/24 00:00 [pmc-release] AID - 00005792-202109240-00030 [pii] AID - MD-D-20-12990 [pii] AID - 10.1097/MD.0000000000027238 [doi] PST - ppublish SO - Medicine (Baltimore). 2021 Sep 24;100(38):e27238. doi: 10.1097/MD.0000000000027238.